↓ Skip to main content

Hydrogen Therapy may be a Novel and Effective Treatment for COPD

Overview of attention for article published in Frontiers in Pharmacology, January 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

twitter
28 X users
peer_reviews
1 peer review site
facebook
4 Facebook pages
video
1 YouTube creator

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Hydrogen Therapy may be a Novel and Effective Treatment for COPD
Published in
Frontiers in Pharmacology, January 2011
DOI 10.3389/fphar.2011.00019
Pubmed ID
Authors

Shu-Lin Liu, Kan Liu, Qiang Sun, Wen-Wu Liu, Heng-Yi Tao, Xue-Jun Sun

Abstract

The protective effect of hydrogen (H(2)) on ROS-induced diseases has been proved by many researches, which demonstrated that through eliminating •OH and •ONOO-, H(2) could effectively attenuate lipid and DNA peroxidation, improve cellular antioxidant capacity, and then protect cells against oxidant damage. Most of free radicals in human body are ROS, including O(2)•-,•OH, H(2)O(2), NO•,•ONOO-, and so on. Under normal circumstances cells are able to maintain an adequate homeostasis between the formation and removal of ROS through particular enzymatic pathways or antioxidants. But under some pathological conditions, the balance is disturbed, leading to oxidative stress and various diseases, such as chronic obstructive pulmonary disease (COPD). Studies have shown that ROS played a pivotal role in the development of COPD and some antioxidants were effective in the protection against the damaging effects of oxidative stress. Therefore, we hypothesize that owing to its peculiarity to eliminate toxic ROS, hydrogen therapy may be a novel and effective treatment for COPD.

X Demographics

X Demographics

The data shown below were collected from the profiles of 28 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 25%
Student > Postgraduate 2 13%
Other 1 6%
Student > Ph. D. Student 1 6%
Student > Doctoral Student 1 6%
Other 2 13%
Unknown 5 31%
Readers by discipline Count As %
Medicine and Dentistry 7 44%
Nursing and Health Professions 2 13%
Chemical Engineering 1 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Unknown 5 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 June 2021.
All research outputs
#1,436,098
of 25,774,185 outputs
Outputs from Frontiers in Pharmacology
#552
of 20,004 outputs
Outputs of similar age
#7,123
of 192,579 outputs
Outputs of similar age from Frontiers in Pharmacology
#3
of 51 outputs
Altmetric has tracked 25,774,185 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,004 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 192,579 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.